Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Foods ; 12(13)2023 Jun 23.
Article in English | MEDLINE | ID: mdl-37444194

ABSTRACT

This cross-sectional study aimed to investigate the prevalence and clinical characteristics of cross-reactivity and co-allergy to other plant foods among adult patients with IgE-mediated banana allergy in Thailand. A structured questionnaire was used to assess clinical reactivity, and cross-reactivity diagnoses were based on reactions occurring within 2 years of banana allergy onset, within 3 h of intake, and confirmed by allergists. Among the 133 participants, the most commonly associated plant foods with clinical reactions were kiwi (83.5%), avocado (71.1%), persimmon (58.8%), grapes (44.0%), and durian (43.6%). Notably, 26.5% of the reported reactions to other plant foods were classified as severe. These findings highlight the common occurrence of cross-reactivity/co-allergy to other plant foods in banana-allergic patients, with a significant proportion experiencing severe reactions. Travelers to tropical regions should be aware of this risk and advised to avoid specific banana cultivars and plant foods with reported high cross-reactivity. The inclusion of self-injectable epinephrine in the management plan for patients with primary banana allergy should be considered due to the substantial proportion of reported severe reactions and the wide range of clinical cross-reactivity and co-allergy observed.

2.
J Autoimmun ; 41: 79-86, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23352659

ABSTRACT

Environmental stimulation is a major factor in the initiation and perpetuation of autoimmune diseases. We have addressed this issue and focused on primary biliary cirrhosis (PBC), an autoimmune disease of the liver. Immunologically, PBC is distinguished by immune mediated destruction of the intra hepatic bile ducts and the presence of high titer antimitochondrial autoantibodies (AMA) directed against a highly specific epitope within the lipoic acid binding domain of the pyruvate dehydrogenase E2 subunit (PDC-E2). We submit that the uniqueness of AMA epitope specificity and the conformational changes of the PDC-E2 lipoyl domain during physiological acyl transfer could be the lynchpin to the etiology of PBC and postulate that chemical xenobiotics modification of the lipoyl domain of PDC-E2 is sufficient to break self-tolerance, with subsequent production of AMA in patients with PBC. Indeed, using quantitative structure activity relationship (QSAR) analysis on a peptide-xenobiotic conjugate microarray platform, we have demonstrated that when the lipoyl domain of PDC-E2 was modified with specific synthetic small molecule lipoyl mimics, the ensuing structures displayed highly specific reactivity to PBC sera, at levels often higher than the native PDC-E2 molecule. Hereby, we discuss our recent QSAR analysis data on specific AMA reactivity against a focused panel of lipoic acid mimic in which the lipoyl di-sulfide bond are modified. Furthermore, data on the immunological characterization of antigen and Ig isotype specificities against one such lipoic acid mimic; 6,8-bis(acetylthio)octanoic acid (SAc), when compared with rPDC-E2, strongly support a xenobiotic etiology in PBC. This observation is of particular significance in that approximately one third of patients who have taken excessive acetaminophen (APAP) developed AMA with same specificity as patients with PBC, suggesting that the lipoic domain are a target of APAP electrophilic metabolites such as NAPQI. We submit that in genetically susceptible hosts, electrophilic modification of lipoic acid in PDC-E2 by acetaminophen or similar drugs can facilitate loss of tolerance and lead to the development of PBC.


Subject(s)
Autoantibodies/immunology , Liver Cirrhosis, Biliary/immunology , Pyruvate Dehydrogenase Complex/immunology , Xenobiotics/immunology , Acetaminophen/adverse effects , Acetaminophen/immunology , Acetaminophen/metabolism , Analgesics, Non-Narcotic/adverse effects , Analgesics, Non-Narcotic/immunology , Analgesics, Non-Narcotic/metabolism , Binding Sites/genetics , Binding Sites/immunology , Epitopes/chemistry , Epitopes/immunology , Epitopes/metabolism , Humans , Liver Cirrhosis, Biliary/blood , Liver Cirrhosis, Biliary/etiology , Models, Immunological , Models, Molecular , Molecular Structure , Protein Binding/immunology , Protein Structure, Tertiary , Protein Subunits/chemistry , Protein Subunits/immunology , Protein Subunits/metabolism , Pyruvate Dehydrogenase Complex/chemistry , Pyruvate Dehydrogenase Complex/metabolism , Thioctic Acid/chemistry , Thioctic Acid/immunology , Thioctic Acid/metabolism , Xenobiotics/adverse effects , Xenobiotics/metabolism
3.
Hepatology ; 57(4): 1498-508, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23184636

ABSTRACT

UNLABELLED: Antimitochondrial antibodies (AMAs) directed against the lipoyl domain of the E2 subunit of pyruvate dehydrogenase (PDC-E2) are detected in 95% of patients with primary biliary cirrhosis (PBC) and are present before the onset of clinical disease. The recent demonstration that AMAs recognize xenobiotic modified PDC-E2 with higher titers than native PDC-E2 raises the possibility that the earliest events involved in loss of tolerance are related to xenobiotic modification. We hypothesized that reactivity to such xenobiotics would be predominantly immunoglobulin M (IgM) and using sera from a large cohort of PBC patients and controls (n = 516), we examined in detail sera reactivity against either 6,8-bis(acetylthio) octanoic acid (SAc)-conjugated bovine serum albumin (BSA), recombinant PDC-E2 (rPDC-E2) or BSA alone. Further, we also defined the relative specificity to the SAc moiety using inhibition enzyme-linked immunosorbent assay (ELISA); SAc conjugate and rPDC-E2-specific affinity-purified antibodies were also examined for antigen specificity, isotype, and crossreactivity. Reactivity to SAc conjugates is predominantly IgM; such reactivity reflects a footprint of previous xenobiotic exposure. Indeed, this observation is supported by both direct binding, crossreactivity, and inhibition studies. In both early and late-stage PBC, the predominant Ig isotype to SAc is IgM, with titers higher with advanced stage disease. We also note that there was a higher level of IgM reactivity to SAc than to rPDC-E2 in early-stage versus late-stage PBC. Interestingly, this finding is particularly significant in light of the structural similarity between SAc and the reduced form of lipoic acid, a step which is similar to the normal physiological oxidation of lipoic acid. CONCLUSION: Specific modifications of the disulfide bond within the lipoic-acid-conjugated PDC-E2 moiety, i.e., by an electrophilic agent renders PDC-E2 immunogenic in a genetically susceptible host.


Subject(s)
Antibodies, Anti-Idiotypic/immunology , Liver Cirrhosis, Biliary/etiology , Liver Cirrhosis, Biliary/immunology , Mitochondria/immunology , Xenobiotics/adverse effects , Antibody Specificity , Autoantigens/immunology , Case-Control Studies , Cholangitis, Sclerosing/blood , Cholangitis, Sclerosing/immunology , Dihydrolipoyllysine-Residue Acetyltransferase/immunology , Hepatitis, Autoimmune/blood , Hepatitis, Autoimmune/immunology , Humans , Immunoglobulin M/blood , Liver Cirrhosis, Biliary/blood , Mitochondrial Proteins/immunology , Recombinant Proteins/immunology , Serum Albumin, Bovine/immunology
4.
J Autoimmun ; 37(3): 209-16, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21763105

ABSTRACT

Our laboratory has hypothesized that xenobiotic modification of the native lipoyl moiety of the major mitochondrial autoantigen, the E2 subunit of the pyruvate dehydrogenase complex (PDC-E2), may lead to loss of self-tolerance in primary biliary cirrhosis (PBC). This thesis is based on the finding of readily detectable levels of immunoreactivity of PBC sera against extensive panels of protein microarrays containing mimics of the inner lipoyl domain of PDC-E2 and subsequent quantitative structure-activity relationships (QSARs). Importantly, we have demonstrated that murine immunization with one such mimic, 2-octynoic acid coupled to bovine serum albumin (BSA), induces anti-mitochondrial antibodies (AMAs) and cholangitis. Based upon these data, we have focused on covalent modifications of the lipoic acid disulfide ring and subsequent analysis of such xenobiotics coupled to a 15mer of PDC-E2 for immunoreactivity against a broad panel of sera from patients with PBC and controls. Our results demonstrate that AMA-positive PBC sera demonstrate marked reactivity against 6,8-bis(acetylthio)octanoic acid, implying that chemical modification of the lipoyl ring, i.e. disruption of the S-S disulfide, renders lipoic acid to its reduced form that will promote xenobiotic modification. This observation is particularly significant in light of the function of the lipoyl moiety in electron transport of which the catalytic disulfide constantly opens and closes and, thus, raises the intriguing thesis that common electrophilic agents, i.e. acetaminophen or non-steroidal anti-inflammatory drugs (NSAIDs), may lead to xenobiotic modification in genetically susceptible individuals that results in the generation of AMAs and ultimately clinical PBC.


Subject(s)
Autoantibodies/blood , Autoantigens/immunology , Autoimmunity , Cholangitis/immunology , Dihydrolipoyllysine-Residue Acetyltransferase/immunology , Liver Cirrhosis, Biliary/immunology , Mitochondria/immunology , Mitochondrial Proteins/immunology , Acetaminophen/administration & dosage , Acetaminophen/adverse effects , Acetaminophen/chemistry , Acetaminophen/immunology , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/chemistry , Anti-Inflammatory Agents, Non-Steroidal/immunology , Autoantibodies/immunology , Autoantigens/blood , Cattle , Cholangitis/blood , Cholangitis/etiology , Enzyme-Linked Immunosorbent Assay , Fatty Acids, Monounsaturated/chemistry , Fatty Acids, Monounsaturated/immunology , Humans , Hydrophobic and Hydrophilic Interactions , Liver Cirrhosis, Biliary/blood , Liver Cirrhosis, Biliary/etiology , Mice , Mitochondria/chemistry , Protein Structure, Tertiary , Quantitative Structure-Activity Relationship , Serum Albumin/chemistry , Serum Albumin/immunology , Thioctic Acid/immunology , Thioctic Acid/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...